Abstract
Major advances in developing models for pharmacokinetic studies have been made in recent years, and different approaches can now be employed. These include the use of (1) compartmental models, (2) non-compartmental models, (3) physiological models, (4) population pharmacokinetic models, and (5) pharmacokinetic-pharmacodynamic models.
Each of these approaches has both advantages and disadvantages. The important question of which of these is ‘ideal’ in veterinary pharmacokinetics has no simple answer. The selection and application of any one approach would depend on a number of factors, such as (1) the purpose of the study, (2) physicochemical properties and actions of drug, (3) specificity and sensitivity of the analytical methodology, (4) species of the animal, and (5) availability of funds.
This paper reviews the models available for pharmacokinetic studies and indicates their possible application in veterinary pharmacology.
Similar content being viewed by others
References
Aliu, Y.O. and Odegaard, S., 1985. Pharmacokinetics of diminazene in sheep. Journal of Pharmacokinetics and Biopharmaceutics, 13, 173–184
Baggot, J.D., 1977. Principles of drug disposition in domestic animals. The Basis of Veterinary Clinical Pharmacology, (W.B. Saunders, Philadelphia)
Baggot, J.D., 1983. Clinical utility and limitations of pharmacokinetics. In: Y.Ruckebusch, P.L.Toutain and G.D.Koritz, (eds.), Veterinary Pharmacology and Toxicology. Proceedings from the 2nd European Association for Veterinary Pharmacology and Toxicology, Toulouse, France, 1982, (MTP Press, Lancaster)
Beal, S.L., 1984. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug Metabolism Reviews, 15, 173–193
Beal, S.L., 1987. Some clarifications regarding moments of residence times with pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics, 15, 75–92
Benet, L.Z., 1985. Mean residence time in the body versus mean residence time in the central compartment. Journal of Pharmacokinetics and Biopharmaceutics, 13, 555–558
Benet, L.Z. and Galeazzi, R.L., 1979. Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences, 68, 1071–1074
Bialer, M., 1980. A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes. Journal of Pharmacokinetics and Biopharmaceutics, 8, 111–113
Bischoff, K.B. and Dedrick, R.L., 1968. Thiopental pharmacokinetics. Journal of Pharmaceutical Sciences, 57, 1346–1351
Bretzlaff, K.N., Neff-Davis, C.A., Ott, R.S., Koritz, G.D., Gustafsson, B.K. and Davis, L.E., 1987. Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils. Journal of Veterinary Pharmacology and Therapeutics, 10, 233–240
Chay, S., Wood, W.E., Nugent, T. and Blake, J., 1982. The pharmacology of nonsteroidal anti-inflammatory drugs in the horse: flunixin meglumine (BenamineR). Equine Practice, 4, 16–23
Chen, C.N., Coleman, D.L., Andrade, J.D. and Temple, A.R., 1978. Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs and tissues. Journal of Pharmaceutical Sciences, 67, 38–45
Chennavasin, P., Johnson, R.A. and Brater, D.C., 1981. Variability in derived parameters of furosemide pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 9, 623–633
Cobelli, C. and Toffolo, G., 1984. Compartmental vs. noncompartmental modeling for two accessible pools. American Journal of Physiology, 247, (Regulatory Integrative and Comparative Physiology, 16) R488-R496
Colburn, W.A., 1981. Simultaneous pharmacokinetic and pharmacodynamic modeling. Journal of Pharmacokinetics and Biopharmaceutics, 9, 367–388
Colburn, W.A., 1987. Pharmacokinetic/pharmacodynamic modeling: What it is! Journal of Pharmacokinetics and Biopharmaceutics, 15, 545–553
Colburn, W.A. and Jack, M.L., 1987. Relationships among CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines. Clinical Pharmacokinetics, 13, 179–190
Cutler, D.J., 1978. Theory of the mean absorption time; an adjunct to conventional bioavailability studies. Journal of Pharmacy and Pharmacology, 30, 476–478
D'Argenio, D.Z., 1981. Optimal sampling times for pharmacokinetic experiments. Journal of Pharmacokinetics and Biopharmaceutics, 9, 739–756
Davis, L.E., Neff-Davis, C.A., Koritz, G.D., Bevill, R.F., Sharma, G.C., Langston, V.C. and Munsiff, I.J., 1987. Effect of organic vehicles on the pharmacokinetics of aminophylline administered intravenously to goats. Journal of Veterinary Pharmacology and Therapeutics, 10, 144–149
Dedrick, R.L., Forrester, D.D., Cannon, J.N., El Dareer, S.M. and Mellett, L.B., 1973. Pharmacokinetics of 1-β-D-arabinosylcytosine (ara-c) deamination in several species. Biochemical Pharmacology, 22, 2405–2417
Dedrick, R.L., Forrester, D.D. and Ho, D.H.W., 1972. In vitro and in vivo correlation of drug metabolism-deamination of 1-β-D-arabinofuranosylcytosine. Biochemical Pharmacology, 21, 1–16
Delbeke, F.T., Debackere, M., Desmet, N. and Stevens, M., 1986. Pharmacokinetics and diuretic effect of bumetanide following intravenous and intramuscular administration to horses. Journal of Veterinary Pharmacology and Therapeutics, 9, 310–317
DiStefano, J.J.III., 1982. Noncompartmental vs. compartmental analysis: some bases for choice. American Journal of Physiology, 243, (Regulatory, Integrative and Comparative Physiology, 12) R1-R6
DiStefano, J.J.III. and Landaw, E., 1984. Multiexponential, multicompartmental, and noncompartmental modeling. I. Methodological limitations and physiological interpretations. American Journal of Physiology, 246, (Regulatory, Integrative and Comparative Physiology, 15) R651-R664
Dunne, A., 1986. An iterative curve stripping technique for pharmacokinetic parameter estimation. Journal of Pharmacy and Pharmacology, 38, 97–101
Fluhler, H., Huber, H., Widmer, E. and Brechbuhler, S., 1984. Experiences in the application of NONMEM to pharmacokinetic data analysis. Drug Metabolism Reviews, 15, 317–339
Fuseau, E. and Sheiner, L.B., 1984. Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model. Clinical Pharmacology and Therapeutics, 35, 733–741
Gerlowski, L.E. and Jain, R.K., 1983. Physiologically based pharmacokinetic modeling; principles and applications. Journal of Pharmaceutical Sciences, 72, 1103–1127
Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics, 2nd edn. (Marcel Dekker, New York)
Hanna, R.M., Borchard, R.E. and Schmidt, S.L., 1988. Effect of diuretics on ketamine and sulfanilate elimination in cats. Journal of Veterinary Pharmacology and Therapeutics, 11, 121–129
Harris, P.A. and Gross, J.F., 1975. Preliminary pharmacokinetic model for adriamycin. Cancer Chemotherapy Reports, 54, 819–825
Himmelstein, K.J. and Lutz, R.J., 1979. A review of the applications of physiologically based pharmacokinetic modeling. Journal of Pharmacokinetics and Biopharmaceutics, 7, 127–145
Holford, N.H.G. and Sheiner, L.B., 1981. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics, 6, 429–453
Jernigan, A.D., Wilson, R.C., Booth, N.H., Hatch, R.C. and Akbari, A., 1988a. Comparative pharmacokinetics of yohimbine in steers, horses and dogs. Canadian Journal of Veterinary Research, 52, 172–176
Jernigan, A.D., Wilson, R.C., Hatch, R.C. and Kemp, D.T., 1988b. Pharmacokinetics of gentamicin after intravenous, intramuscular, and subcutaneous administration in cats. American Journal of Veterinary Research, 49, 32–35
Kinabo, L.D.B. and Bogan, J.A., 1988a. Solid-phase extraction and ion-pair reversed-phase HPLC of isometamidium in bovine serum and tissues. Acta Tropica, 45, 165–170
Kinabo, L.D.B. and Bogan, J.A., 1988b. Pharmacokinetic and histopathological investigations of isometamidium in cattle. Research in Veterinary Science, 44, 267–269
Kinabo, L.D.B. and Nielsen, P., 1986. Sulfatroxazole: pharmacokinetics, metabolism and urinary excretion in goats and pigs. Journal of Veterinary Pharmacology and Therapeutics, 9, 55–62
Kleinbloesem, C.H., van Brumelen, P. and Breimer, D.D., 1987. Nifedipine: relationship between pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 12, 12–29
Knoppert, N.W., Nijmeijer, S.M., van Duin, C.T.M., Korstanje, C., van Gogh, H. and van Miert, A.S.J.P.A.M., 1988. Some pharmacokinetic data of aditoprim and trimethoprim in healthy and tick-borne fever infected dwarf goats. Journal of Veterinary Pharmacology and Therapeutics, 11, 135–144
Koritz, G.D., 1983. Influence of ruminant gastrointestinal physiology on the pharmacokinetics of drugs in dosage forms administered orally. In: Y.Ruckebusch, P.L.Toutain and G.D.Koritz, (eds.), Veterinary Pharmacology and Toxicology. Proceedings from the 2nd European Association for Veterinary Pharmacology and Toxicology, Toulouse, France, 1982, (MTP Press, Lancaster) pp. 151–163
Koritz, G.D., McKiernan, B.C., Neff-Davis, C.A. and Munsiff, I.J., 1986. Bioavailability of four slow-release theophylline formulations in the Beagle dog. Journal of Veterinary Pharmacology and Therapeutics, 9, 293–302
Landaw, E. and DiStefano, J.J.III., 1984. Multiexponential, multicompartmental, and noncompartmental modeling. III. Data analysis and statistical considerations. American Journal of Physiology, 246, (Regulatory, Integrative and Comparative Physiology, 15), R665-R677
Lees, P., Ayliffe, T., Maitho, T.E. and Taylor, J.B.O., 1988. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration. Research in Veterinary Science, 44, 57–67
Lutz, R.J., Galbraith, W.M., Dedrick, R.L., Shrager, R. and Mellet, L.B., 1977. A model for the kinetics of distribution of actinomycin in the beagle dog. Journal of Pharmacology and Experimental Therapeutics, 200, 469–478
Mintun, M., Himmelstein, K.J., Schroder, R.L., Gibaldi, M. and Shen, D.D., 1980. Tissue distribution kinetics of tetraethylammonium ion in the rat. Journal of Pharmacokinetics and Biopharmaceutics, 8, 373–409
Notari, R.E., 1975. Biopharmaceutics and Pharmacokinetics: an Introduction, 2nd edn. (Marcel Dekker, New York)
Nuesch, E.A., 1984. Noncompartmental approach in pharmacokinetics using moments. Drug Metabolism Reviews, 15, 103–131
Odegaard, S.A. and Rastaad, A., 1987. Pharmacokinetics of sulphaphenazole in cattle. Journal of Veterinary Pharmacology and Therapeutics, 10, 83–84
Paalzow, L.K., 1984. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS. Drug Metabolism Reviews, 15, 383–400
Pedersen, P.V., 1977. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. Journal of Pharmacokinetics and Biopharmaceutics, 5, 513–531
Rescigno, A. and Beck, J.S., 1987. The use and abuse of models. Journal of Pharmacokinetics and Biopharmaceutics, 15, 327–340
Riegelman, S. and Collier, P., 1980. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. Journal of Pharmacokinetics and Biopharmaceutics, 8, 509–534
Riond, J.-L. and Riviere, J.E., 1988. Multiple intravenous dose pharmacokinetics and residue depletion profile of gentamicin in pigs. Journal of Veterinary Pharmacology and Therapeutics, 11, 210–214
Riviere, J.E., 1988. Veterinary clinical pharmacokinetics. Part II. modeling. Compendium on continuing education for the practising veterinarian, 10, 314–328
Rowland, M., 1984. Physiologic pharmacokinetic models: Relevance, experience, and future trends. Drug Metabolism Reviews, 15, 55–74
Rowland, M. and Tucker, G., 1980. Symbols in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 8, 497–507
Sanders, P., Guillot, P. and Mourot, D., 1988. Pharmacokinetics of a long-acting chloramphenicol formulation administered by intramuscular and subcutaneous routes in cattle. Journal of Veterinary Pharmacology and Therapeutics, 11, 183–190
Sedman, A.J. and Wagner, J.G., 1976. CSTRIP, a Fortran IV computer program for obtaining initial polyexponential parameter estimates. Journal of Pharmaceutical Sciences, 65, 1006–1010
Segre, G., 1984. Relevance, experiences and trends in the use of compartmental models. Drug Metabolism Reviews, 15, 7–53
Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N., 1985. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. American Journal of Veterinary Research, 46, 2474–2479
Sheiner, L.B., 1984. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metabolism Reviews, 15, 153–171
Sheiner, L.B., 1987. Commentary to pharmacokinetic/pharmacodynamic modeling: What it is! Journal of Pharmacokinetics and Biopharmaceutics, 15, 553–555
Sheiner, L.B., Stanski, D.R., Vozeh, S., Miller, R.D. and Ham, J., 1979. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clinical Pharmacology and Therapeutics, 25, 358–371
Short, C.R. and Lees, P., 1984. Editorial. Journal of Veterinary Pharmacology and Therapeutics, 7, 253–254
Soback, S., 1988. Pharmacokinetics of single doses of cefoxitin given by the intravenous and intramuscular routes to unweaned calves. Journal of Veterinary Pharmacology and Therapeutics, 11, 155–162
Soback, S. and Ziv, G., 1988. Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves. American Journal of Veterinary Research, 49, 535–538
Steimer, J.L., Mallet, A., Golmard, J.L. and Boisvieux, J.F., 1984. Alternative approaches to estimation of population pharmacokinetic parameters: Comparison with the nonlinear mixed-effect model. Drug Metabolism Reviews, 57, 205–240
Teorell, T., 1937. Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Archives Internationale de Pharmacodynamie, 57, 205–225
Unadkat, J.D., Bartha, F. and Sheiner, L.B., 1986. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clinical Pharmacology and Therapeutics, 40, 86–93
Vaughan, D.P. and Hope, I., 1979. Applications of a recirculatory stochastic pharmacokinetic model: Limitations of compartmental models. Journal of Pharmacokinetics and Biopharmaceutics, 7, 207–225
Wagner, J.G., 1976. Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 4, 395–425
Wertz, E.M., Benson, G.J., Thurman, J.C., Tranquilli, W.J., Davis, L.E. and Koritz, G.D., 1988. Pharmacokinetics of thiamylal in cats. American Journal of Veterinary Research, 49, 1079–1083
Wijnand, H.P., 1988. Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal. Journal of Pharmacokinetics and Biopharmaceutics, 16, 109–128
Yamaoka, K., Nakagawa, T. and Uno, T., 1978. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547–558
Ziv, G., Nouws, J.F.M. and Van Ginneken, C.A.M., 1982. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. Journal of Veterinary Pharmacology and Therapeutics, 5, 45–58
Ziv, G., Soback, S., Bor, A. and Kurtz, B., 1986. Clinical pharmacokinetics of flumequine in calves. Journal of Veterinary Pharmacology and Therapeutics, 9, 171–182
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kinabo, L.D.B., McKellar, Q.A. Current models in pharmacokinetics: Applications in veterinary pharmacology. Veterinary Research Communications 13, 141–157 (1989). https://doi.org/10.1007/BF00346724
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00346724